You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨康寧傑瑞製藥(9966.HK)逆勢漲4.78% 多家大行唱多
格隆匯 09-09 15:20
格隆匯9月9日丨康寧傑瑞製藥(9966.HK)今早見近半年低點後反彈,現逆勢漲4.78%,報14.46港元,總市值135億港元。摩根士丹利發表最新報告表示,康寧傑瑞生物製藥股價在未來30天上升,發生此概率介乎70%至80%。考慮到公司產品線近期有多個催化劑,給予目標價20港元,評級“增持”。里昂此前發表報告指,集團治療膽管癌新藥KN035(Envafolimab)的臨牀進展令人鼓舞,料於今年第四季作生物製品上市申請(BLA),而治療非小細胞肺癌的另一新藥KN046亦進入三期臨牀,目標價由17.39港元升至21港元,評級維持買入。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account